J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Orignial Source:

https://www.foxbusiness.com/lifestyle/jjs-ketamine-derived-nasal-spray-approved-fda-treat-depression

Sidebar

Financial News

J&J's ketamine-derived nasal spray approved by FDA to treat depression

National Weather